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Available online 25 January 2016Background:About twenty variants of apolipoproteinA-I (ApoA-I) are associated to hereditary systemic amyloid-
oses. Although themolecular bases of this disease are still largely unknown, it has been hypothesized that ApoA-I
proteolysis is a key event in pathogenesis, since it triggers the release of anN-terminal fragment (80–100 residue
long) thatmisfolds to formamyloid deposits in peripheral organs and tissues. It is also known that cellmembrane
lipids play a key role in the ﬁbrillogenic pathway. In the case of ApoA-I related amyloidosis caused by L174Smu-
tation, the 93-residue N-terminal fragment of ApoA-I ([1-93]ApoA-I) was found to be the major constituent of
ex vivo ﬁbrils.
Methods:With the main goal to investigate the interaction of either [1-93]ApoA-I and ApoA-I with biomimetic
membranes, we set-up an experimental system based on the Raman Tweezers methodology. We tested GUVs
composed by two types of zwitterionic lipids with a different ﬂuidity degree, i.e. dioleoylphosphatidylcholine
(DOPC) and dipalmitoylphosphatidylcholine (DPPC).
Results: We found that [1-93]ApoA-I induces conformational disorder in an ordered lipid bilayer. When
interacting with ﬂuid phases, instead, the fragment was found to be able to penetrate the membrane bilayer in-
ducing an alignment of lipid chains.
Conclusions: The interaction features of [1-93]ApoA-I with biomimetic membranes strongly depend on the lipid
phase. Full-length ApoA-I was found to have similar effects, even if signiﬁcantly less pronounced.
General signiﬁcance: Our observations shed light on still largely unknownmolecular bases of ApoA-I ﬁbrillogenic
domain interaction with membranes.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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It is known that the interaction of proteinswith chemical groups ex-
posed on a membrane surface is able to modify their conformational
states [1–3]. On the other hand, it has also been reported that proteins
can alter membrane ﬂuidity, and/or permeate the membrane bilayer,
eventually extracting membrane lipids [4]. In the case of natively un-
folded polypeptides, it has been demonstrated that, upon interaction
with surfaces, they readily adopt helical structures that represent key
intermediates in the amyloid formation process [5]. In particular, anion-
ic surfaces and anionic phospholipid-richmembranes can play key roles
either in triggering protein–protein aggregation (ﬁbrillogenesis) by act-
ing as conformational catalysts for amyloid ﬁbril deposition [1], or as in-
hibitors of ﬁbrillogenesis [6].
Membranes also play a key role in amyloidoses associated with
speciﬁc variants of apolipoprotein A-I (ApoA-I), the major structural.component of high density lipoproteins (HDL). Speciﬁc ApoA-I mu-
tations are responsible for well-known familial systemic amyloidosis
[7], characterized by amyloid deposition in peripheral organs, such
as heart, liver or kidneys. In rarer cases, amyloid is also found in
the testes and adrenal glands [7–9]. Notably, the molecular bases of
the onset and development of this pathology are still largely
unknown.
The prevailing concept in this ﬁeld is that ApoA-I proteolysis is a key
event in the development of the disease, since it triggers the release of
the N-terminal fragment (80–100 residue long) that misfolds to form
amyloid deposits [10]. In both lipid-bound and lipid-free ApoA-I, this re-
gion 80–100 forms well-ordered helical structures [11–13] and is ex-
pected to be protected from proteolysis. Nevertheless, it is emerging
that a single point amyloidogenic mutation is able to profoundly alter
the protein 3D structure, thus presumably exposing protein regions to
proteolytic attack. In ApoA-I amyloidosis caused by the presence of
L174S mutation, the 93-residue N-terminal polypeptide of ApoA-I
(henceforth denoted as [1-93]ApoA-I) was found to be the major con-
stituent of ex vivo ﬁbrils [14]. Recently, we produced a recombinant
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aqueous solutions at pH 7.0 [15]. Upon acidiﬁcation to pH 4.0, we ob-
served a conformational transition towards a helical state, which we
have proposed to be a key intermediate in the ﬁbrillogenic pathway,
leading to the formation of a β-sheet-based polymeric structure that
evolves into typical amyloid ﬁbrils [15]. Moreover, we also demonstrat-
ed that a lipid environment induces and stabilizes helical intermediates
of [1-93]ApoA-I, thus affecting its aggregation pathway [16]. This is
noteworthy considering that ApoA-I functional role is strictly related
to its interactions with lipids and that the N-terminal region of ApoA-I
contributes to the binding of the native protein to lipids [17–18]. In par-
ticular, cholesterol, a natural ApoA-I ligand, is able to induce a transition
towards a helical conformation and to inhibit protein aggregation in a
concentration- and time-dependentmanner [16]. Similar to cholesterol,
zwitterionic, negatively and positively charged liposomeswere found to
be able to increase the helical content, with negatively charged lipo-
somes showing the greatest effect in inducing helical species [16].
The work presented herein is committed to shed light on the interac-
tion of the ﬁbrillogenic polypeptide [1-93]ApoA-I with cellular
membranes. It has to be noticed that interaction of unaggregated [1-
93]ApoA-I with cell membranes represents a key event in the develop-
ment of ApoA-I associated amyloidoses, but molecular details and conse-
quences of this interaction are still largely unknown.We investigated the
role of membrane ﬂuidity by taking advantage of the use of Giant
Unilamellar Vesicles (GUVs) as synthetic biomimetic systems. GUVs are
spherical phospholipid bilayers entrapping a closedwater-ﬁlled compart-
ment [19], typically used to gain insight intomembrane organization and
response to external agents. Plasmamembrane of eukaryotic cellsmay be
considered as composed of small ﬂuid domains, in which lipids are ar-
ranged in a liquid–crystalline phase nucleated within a continuous,
more ordered gel phase [20]. Hence, in order to properly simulate these
membrane phases, we used GUVs composed of two kinds of zwitterionic
lipids endowed with different ﬂuidity properties, such as dioleoylphos-
phatidylcholine (DOPC) and dipalmitoylphosphatidylcholine (DPPC).
Since DOPC andDPPCmelting temperatures are−16.5 °C and 41.3 °C, re-
spectively, they are representative of the ﬂuid-like state L α (DOPC) and of
the gel state L β (DPPC) at room temperature (T = 24 °C) [21]. Analyses
were performed by taking advantage of Raman Tweezers (RT) methodol-
ogy, i.e. the combination of a Raman spectrometer and an Optical
Tweezers (OT) [22]system [23]. This approach presents speciﬁc beneﬁts
with respect to well-consolidated techniques used to investigate mem-
brane properties, such as Differential Scanning Calorimetry (DSC) [24],
and ﬂuorescence-based techniques [25,26]. As a matter of fact, RT can
beused to trap and interrogate single objects, in order to provide informa-
tion on their chemical components, without the need of sample labeling.
Moreover, the analysis of Raman spectra is able to revealmolecular details
of protein species/lipid interaction features. In particular, on the bases of
selected Raman band changes, it is possible to identify the speciﬁc lipid
moieties involved into the interaction with proteins. Furthermore, the
use of OT allows the investigation of GUVs in the absence of any
surface-induced spurious effect. Furthermore, RT allows the acquisition
of the signal from a single GUV, thus giving the possibility to explore the
heterogeneity of the system under investigation. In the present study,
GUV manipulation by OT, combined with the non-destructive nature of
Raman spectroscopy, gave us the opportunity to follow over time the in-
teraction of single GUVs with the proteins under test. Being Raman spec-
tra sensitive to molecular conformations, we were able to observe the
reorganization of GUV phospholipid bilayer upon interaction with
ApoA-I or with [1-93]ApoA-I. Interestingly, our results, besides revealing
that [1-93]ApoA-I plays a key role in ruling ApoA-I interactionwithmem-
branes, indicate that the interaction of the ﬁbrillogenic polypeptide with
DPPC–GUVs has effects that resemble lipid phase transition induced by
melting. Instead, the interaction with DOPC-based bilayers induces an
alignment ofmembrane lipid chains, similar to that induced by cholester-
ol [27]. The same phenomena, even if signiﬁcantly less pronounced, were
observed for full-length ApoA-I.2. Material and methods
2.1. Proteins under test
ApoA-I was purchased from Sigma-Aldrich (St Louis, MO, USA). [1-
93]ApoA-I polypeptide was expressed and puriﬁed as previously de-
scribed [16], omitting the neutralization step with ammonium hydrox-
ide. The ﬁnal yield of the procedure was estimated to be 2.5 mg/L of
bacterial culture. Pure [1-93]ApoA-I was lyophilized and stored at
−70 °C until use. For experimental purposes, the polypeptide was dis-
solved in the appropriate buffer and centrifuged before use.
2.2. Experimental set-up
The Raman analysis presented in this work was performed by using
a combined Optical Tweezers and micro-Raman system. The set-up has
been described in detail elsewhere [23,28]. Brieﬂy, it consisted essen-
tially in a home-made inverted microscope, endowed with a trapping
beam (Nd:YAG, 1064 nm, Ventus 1064) and a Raman probe at 532 nm
(Spectra Physics Millennia Xs). The microscope was equipped with a
100× objective lens (Olympus oil-immersion inﬁnity corrected objec-
tive, 1.4 N.A.), in which both lasers were injected through a dichroic
mirror, reﬂecting near-IR radiation and being transparent to visible ra-
diation. The back-scattered photons followed back along the same opti-
cal pathway, reaching ﬁnally a holographic notch ﬁlter where the
elastically scattered photons were suppressed. The resulting radiation
was focused through a 50 μm aperture pinhole for confocal detection
geometry and subsequently sent to a spectrometer (TRIAX 180, Jobin-
Yvon) for the spectral analysis. The Raman radiation was detected by
using a thermoelectrically cooled charge-coupled device (Pixis 100,
Princeton Instruments), at the spectrometer exit. Raman spectra were
acquired in the 900–1800 cm−1 spectral range. It should be noticed
that the CH 2/CH 3 stretching bands in the 2800–3000 cm−1 region
also provide information about the order of lipid architecture. However,
in our case, the analysis of Raman bands in this region is complicated by
the presence of the broad Raman bands in the 3000 cm−1 region due to
H 2O. In fact, even if H 2O is a weak scatterer, Raman spectra of GUVs in
aqueous solution present a signiﬁcant contribution from water, due to
the reduced scattering volume from the very thin (~5 nm) GUV mem-
brane. The sample under investigation was placed in a chamber
consisting of two 150 μm glass coverslips (Knittel Glasser, thickness
no.1), sealedwith paraﬁlm stripes, which also act as an ~100 μm spacer.
In order to maximize the GUV signal, the membrane was placed in the
Raman confocal scattering volume by acting on the galvo-mirrors con-
trolling the trapping laser beam position.
2.3. Data analysis
Principal Component Analysis (PCA) is a statistical tool that allows
the decomposition of a multidimensional data set, in order to reduce
its dimensionality while retaining the relevant characteristics contribut-
ing tomost of its variance [29]. Fromamathematical point of view, PCA is
an orthogonal linear transformation that converts the original data (var-
iables) into a new basis of uncorrelated coordinates (Principal Compo-
nents, PCs), which are a linear combination of the original variables.
PCs are ordered on the basis of their contribution to variation, with the
ﬁrst PC exhibiting the greatest contribution. The results of a PCA are
given in terms of component scores and loadings. Loadings are the coef-
ﬁcients of the linear combination deﬁning the PCs, in that they express
the contribution of each original variable to the global variance of data
set. Scores, instead, are the coordinates of the original data in the PC
space. When PCA is applied to Raman spectra, the loadings enable the
identiﬁcation of themore relevant variables (i.e.wavenumbers), provid-
ing information on how they are correlated. Each score represents a
whole spectrum plotted in a three dimensional space (score space),
with points corresponding to similar spectra clustered together [30].
Table 1
Assignment of the prominent Raman features observed in DPPC– and DOPC–
GUVs [32–34,36].
Wavenumber (cm−1) Assignment
1063 SOM (trans)
1080 SOM (gauche)
1098 SOM (trans)
1128 SOM (trans)
1240 PO2- antisym stretch
1264 _C\\H bend
1296 CH2 twist
1440 CH bend in CH2
1460 CH bend in CH3
1655 C_C stretch
1735 C_O stretch
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GUVswere prepared following a procedure similar to that previous-
ly described [19]. Brieﬂy, 3 mg of lipids (DOPC or DPPC) by Avanti were
dissolved in 500 μL of chloroform (0.1 M). An aliquot (20 μL) of this so-
lution was added to 200 μL of methanol and 980 μL of chloroform in a
50 mL round-bottom ﬂask. Water (2.8 mL) was then slowly added
alongside the ﬂask walls. Finally, this solution was rotoevaporated for
3 min at a pressure of 10mbar and a temperature of ~40 °C. This proce-
dure provides vesicles whose diameter is in the range between 1 and
30 μm, as observed by bright ﬁeld microscopy [31]. Vesicles with a di-
ameter in the 4–8 μm range were selected for the experiments.
3. Results and discussion
As ﬁrst, we acquired the Raman spectra of [1-93]ApoA-I and full-
length ApoA-I in aqueous buffer. Fig. 1 shows the spectrum of a
0.76 μM [1-93]ApoA-I (a) and a 7.6 μM ApoA-I (b) aqueous solution in
the spectral range between 900 and 1800 cm−1.
Spectra were acquired by using a Raman probe power of 3 mW and
an integration time τ=30 s. Under these experimental conditions, both
signals exhibit only broad features due to the weak Raman bending
mode around 1640 cm−1, while no signiﬁcant contribution from pro-
teinaceous bands was detected, as a consequence of the low protein
concentration. Trace c and d in Fig. 1 show, instead, the Raman spectra
of an optically trapped DPPC– or DOPC–GUV, respectively, acquired
under the same experimental conditions of traces a and b (no proteins
added). The obtained Raman spectra present spectral features mainly
arising from vibrations of the hydrocarbon chains, withminor contribu-
tion of polar groups. The assignment of the prominent peaks, reported
in Table 1, has been performed on the basis of the criteria reported in
[32–36].
According to these papers, the low-wavelength region is dominated
by skeletal optical modes (SOM). These modes, being mainly C\\C
stretching vibrations delocalized along the entire acyl chain, provide in-
formation on the intrachain conformation. In particular, the relative in-
tensity of trans/gauche peaks can be used to monitor the transition of
a lipid to an ordered/disordered phase [37]. On the other hand, CH
modes are essentially not coupled to the chain and are sensitive to lat-
eral interactions inside the bilayer, so that the strength of these vibra-
tions provides information on the interchain order. In particular,Fig. 1. Representative Raman spectra of proteins and lipids (DPPC and DOPC) under investig
(b) aqueous solution in the spectral range between 900 and 1800 cm−1. Spectra were obtai
DPPC– (c) and DOPC–GUV (d) Raman spectra, acquired under the same experimental conditioaccording to ref. [32], the decrease of the CH bending mode in CH2
with respect to that in CH3 is indicative of a reduced interchain order.
In the case of DOPC–GUV spectrum, a strong feature at 1655 cm−1
takes into account the presence of the C_C bond. Obviously, the ratio
of trans-to-gauche band intensity is larger for DPPC– than for DOPC–
GUV, indicating that there is a higher degree of conformational order
in the fully saturated lipid. After this preliminary step, we proceeded
to investigate the interaction of [1-93]ApoA-I and ApoA-I with DPPC–
and DOPC–GUVs. To this purpose, polypeptide and full-length protein
were incubated with preformed GUVs at a protein:lipid molar ratio of
~1:100, up to 2 h (τﬁn). It should be noticed that, even at a lipid-to-
protein molar ratio of 100:1, the lipid architecture can be signiﬁcantly
perturbed by proteins. As a matter of fact, due to the different sizes of
proteins and lipids, protein–lipid interaction is not a one-to-one interac-
tion. In particular, assuming for ApoA-I an effective diameter of 4.5 nm
(estimated from its molecular weight, 28 kDa) and taking into account
that head group area of one lipid molecule is ~0.71 nm2, it is possible
to estimate that ~25 lipid molecules directly interact with a single full-
length protein. Moreover, it should be also noticed that both full-
length protein and polypeptide can oligomerize in aqueous solution.
In particular, ApoA-I exhibits an apparent hydrodynamic diameter of
11 nm in aqueous solution,which is consistentwith the size of a protein
dimer [38] This means that each dimer potentially interacts with ~130
lipid molecules. For this study, we acquired the Raman spectrum of 40
single, optically trapped GUVs at the initial state (τ0) and at the end of
incubation (τﬁn). Moreover, to follow the kinetics of lipid/proteination. (A) Raman spectra of a 0.76 μM [1–93]ApoA-I (a) and a 7.6 μM full-length ApoA-I
ned with an integration time of 30 s and a power of ~3 mW on the sample. c, d: single
ns in the absence of proteins. (B) Sketch of the chemical structure of DOPC and DPPC.
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2 min for the ﬁrst 30 min, and then every 10min up to 2 h. As a control,
these analyses were performed on simple GUVs (no proteins added).
3.1. Interaction of [1-93]ApoA-I with DPPC–GUVs (gel phase)
Fig. 2A reports typical spectra of DPPC–GUVs analyzed upon incuba-
tion with the polypeptide (trace a) or the full-length protein (trace b),
acquired at τﬁn.
Remarkably, quite relevant changeswith respect to τ0 were observed
in both cases, even if more pronounced in the case of [1-93]ApoA-I. The
main spectral changes involve the region 1170–1270 cm -1, associated
with interactions of the PO 2- groups of the phospholipid polar headmoi-
ety, as well as regions 950–1100 cm -1 and 1400–1480 cm -1, which are
sensitive to variations in the acyl chain order. The most striking differ-
ences speciﬁcally associated with the interaction of [1-93]ApoA-I with
DPPC–GUVs lie in region 1170–1270 cm -1. Actually, two additional
bands are present around 1218 and 1240 cm -1 and appear to be notably
pronounced in the case of Raman spectra of DPPC–GUVs recorded in the
presence of the ﬁbrillogenic polypeptide. These bands aremuch less pro-
nounced in the presence of ApoA-I and appear to be hardly visible in the
absence of proteins (Fig. 1)[35]. According to literature [36], the afore-
mentioned bands are associated with the asymmetric stretching vibra-
tions of the PO 2- groups. In particular, it has been previously reported
that the antisymmetric stretching band lies around 1240 cm -1 in dry
DPPC–GUV and shifts to ~1220 cm -1 in fully hydrated DPPC [36]. From
Fig. 2, it is possible to note that lipid–protein interaction is responsible
for a strong decrease of the all-trans band at 1128 cm -1, as well as of
the band at 1063 cm -1 [37]. On the contrary, the gauchemarker around
1080 cm -1, generally associated with the presence of gauche chainFig. 2. Analysis of the interaction of ApoA-I and [1-93]ApoA-I with DPPC GUVs. (A) Typical norma
protein (trace b), acquired at τﬁn (120 min). (B) Representative ﬁtting curves for a spectrum o
contributions of the four Gaussian curves used as ﬁt functions. Moreover, hatched areas corre
(iii) and δ (iv) mean values obtained by the ﬁtting procedure are exempliﬁed in panel B. The errosegments [37], is signiﬁcantly more pronounced upon DPPC–GUV inter-
action with the ﬁbrillogenic polypeptide. This kind of spectral changes
has been observed at a temperature almost corresponding to the lipid
phase transition [32]. Under these conditions, lipid physical state passes
from the ordered gel phase Iβ (below T c), where the hydrocarbon chains
are fully extended and closely packed, to the more disordered Iα phase
(above T c), where the hydrocarbon chains are randomly oriented and
ﬂuid. In agreement with this, the band around 1440 cm -1 appears to
beweakenedwith respect to that around 1460 cm -1, which is indicative
of a reduced lateral packing, and a consequent more disordered lipid
chain architecture [32,34]. To better assess the differences between the
three analyzed samples, we evaluated the intensity of the most promi-
nent peaks involved in spectral changes by performing a ﬁtting with a
multi peakGaussian function in all the aforementioned regions. In partic-
ular, to properly take into account the presence of all spectral features,
we used a 4 Gaussian convolution for 950–1100 cm -1 region, a 2 Gauss-
ian convolution for 1170–1270 cm -1 region and a 2 Gaussian convolu-
tion for 1400–1480 cm -1 region. In all the cases, a fourth order
polynomial curve was added in order to take into account a residual
background not completely removed by the subtraction of the back-
ground signal. In Fig. 2B, we show a typical result of the ﬁtting procedure
for one of the spectra acquired for the polypeptide in the 950–1100 cm -1
region, at τ=0and τ=τﬁn. The same procedurewas used for all the GUV
spectra acquired for the three investigated samples. Some signiﬁcant
outcomes of this procedure are reported in Fig. 2C.
Inmore detail, panel i) reports themean values of α=(I 1218+I 1240),
i.e. the integrated area under the two aforementioned PO 2- stretching
bands, along with the standard deviations over the 40 GUV spectra. As
mentioned above, this parameter fully differentiates the analyzed sam-
ples, highlighting the ability of the polypeptide to interact with thelized Raman signals of DPPC GUVs upon incubation with [1-93]ApoA-I (trace a) or full-length
f the polypeptide in the region 950–1100 cm−1. The dotted lines represent the separate
spond to the integrated area under the peaks used for evaluation of γ. (C) α (i), β (ii), γ
r bars correspond to the standard deviations over the 40 spectra analyzed for each sample.
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was recorded for the full-length protein. As a matter of fact, it is reason-
able to think that the polypeptide interacts with the PO 2- bond in a man-
ner that induces some modiﬁcations of the PO 2- bond polarizability,
responsible for the enhanced Raman activity. It should be also pointed
out that, differently from the polypeptide sample, the spectra corre-
sponding to the ApoA-I–GUV complex present a consistent ﬂuctuation
of the ratio β= I 1218/I 1240, as reported in Fig. 2C, panel ii. This is clearly
suggestive of a random protein positioning in the lipid head region,
which gives rise to a different environment for the PO 2- bond. Intriguing-
ly, in this frame, the lowerβ value for ApoA-Iwith respect to [193]ApoA-I
could be ascribed to a lower exposure to solvent of the PO 2- bond in the
case of full-length proteinwith respect to its fragment. The two additional
parameters reported in Fig. 2C, namely the ratios γ=I 1128/I 1080
(panel iii) and δ= I 1440/I 1460 (panel iv), are indicative of the protein/
polypeptide interaction with the lipid acyl chains. As discussed above,
their decreasewith respect to the pure lipid case is indicative of a reduced
order for the acyl chain assembly. In particular, the similar γ and δ values
obtained in our analysis clearly prove that the polypeptide shares with
the full-length ApoA-I protein the ability to interact with the lipid mem-
brane bilayer. This, in turn, is likely due to the presence, in both protein
and fragment helices, of a non-polar side, clearly prone to be buried
into the hydrophobic region of the bilayer. Notably, our observations
are in agreement with recently published data indicating that 1-83
ApoA-I peptide, which is part of [1-93]ApoA-I analyzed herein, contains
four most probable membrane-binding regions [39]. Globally, these ob-
servations let us hypothesize that the ApoA-I N-terminal ﬁbrillogenic do-
main is responsible for protein/ﬁbril attachment to the surface of lipid
vesicles.
Interestingly, all the spectral modiﬁcations induced by both poly-
peptide and full-length protein are detected very early (within
~5 min), reaching a steady state within 20 min. Fig. 3A reports the
time evolution of γ obtained for a single optically trapped DPPC–GUV
interacting with [1-93]ApoA-I. A similar evolution has been observed
also for the other parameters evaluated herein, as well as for GUVs
upon interaction with ApoA-I. In both cases, their behavior resembles
a sigmoidal curve, with a transition in the 10–30 min region. This indi-
cates that the interaction of both the ﬁbrillogenic polypeptide and the
full-length protein with DPPC–GUVs have effects that resemble the
lipid phase transition induced by melting, which are much more pro-
nounced in the case of the ﬁbrillogenic polypeptide [32]. This observa-
tion could be also veriﬁed by using DSC on a statistically signiﬁcantFig. 3. Kinetic analysis of protein–DPPC GUV interaction. Time evolution of observed
gamma for a single, optically trapped DPPC–GUV interacting with the polypeptide (A),
the full-length protein (B) and in the absence of proteins (C).number of GUVs. However, it has to be noticed that, in the case of the
approach herein proposed, sample heterogeneity is completelymasked.
3.2. Interaction of [1-93]ApoA-I with DOPC–GUVs (liquid phase)
As mentioned above, the effect of ApoA-I ﬁbrillogenic fragment on
the ﬂuid membrane phase was explored by analyzing its interaction
with DOPC–GUVs at room temperature (~24 °C). However, different
from the DPPC–GUVs case, the spectroscopic effect of this interaction
was not immediately detectable. Although, in principle, this could be as-
cribed to a weak lipid–protein interaction, we argued that this could be
likely due to the obvious difﬁculty in identifying protein effects in a rel-
atively disordered structure. Therefore, in order to appreciate the ﬁne
tuning of DOPC–GUV spectra upon interactionwith proteins, we choose
to analyze our set of data by Principal Component Analysis (PCA). PCA
was performed by using a home-made MATLAB, MathWorks software,
based on theuse of the princomp routine. Before analysis, Raman spectra
were pre-processed by removing a fourth-order polynomial curve and
eliminating spurious signals deriving from cosmic ray contributions.
Spectra were also normalized and mean centered before the decompo-
sition in PCs.
Fig. 4 shows the three-dimensional score plot obtained by analyzing
the 120 spectra for the ﬁrst 3 PCs, which globally take into account al-
most 92% of the total spectra variability (see Fig. 4B) In the score plot,
the symbols corresponding to [1-93]ApoA-I–GUV and ApoA-I–GUV
complexes are triangles and squares, respectively, while spectra corre-
sponding to GUVs are represented by dots. Interestingly, points corre-
sponding to the spectra of each sample tend to be clustered together,
with some overlapping between the two protein-containing systems.
Most of data variability (~75%) is taken into account by PC1. Notably,
PC1 scores of the samples containing the polypeptides and the full-
length protein are quite apart from the pure GUV sample, which, in-
stead, occupy a score plot region of relatively low PC1 score values.
The reason of this differentiation can be ﬁgured out by PC1 loading in-
spection (Fig. 5A) This loading exhibits main features at around
1655 cm -1, associated with oleﬁnic vibrations of unsaturated chain
segments.
In particular, they appear as negative peaks, with some overlapping
with dispersive-like features, indicative of a shift to lowerwavenumbers
of the correspondingRamanpeaks. According to literature [40], a shift of
oleﬁnic vibration to lower wavenumbers can be indicative of an elonga-
tion of the C_C bond. Therefore, positive PC1 scores correspond to
spectra of lipid structures where C_C bond is weakened (negative
load features) and/or elongated (dispersive load features). As PC1, also
PC2 component provides differentiation between the two protein-
containing systems and the pure DOPC–GUVs, although points corre-
sponding to the ﬁrst two samples occupy the same score plot region.
As a matter of fact, the main features of PC2 loading lie in the region
around 1450 cm -1, including the two CH modes around 1440 cm -1
and 1460 cm -1. Clearly, the simultaneous presence of a positive feature
around 1440 cm -1 and a negative feature around 1460 cm -1 suggests
that higher PC2 score values correspond to more ordered lipid struc-
tures. Interestingly, the improved acyl chain order seems to be some-
what related to the shift of oleﬁnic band highlighted by PC1 loading.
In particular, a more ordered acyl chains conﬁguration could result
from a higher interchain pressure, giving rise to a repulsion between
chains lying at opposite sides of the C_C bonds and, as a consequence,
to a C_C bonding elongation. The last PC herein analyzed, PC3, takes
into account about 10% of the total data variability. As for PC2, this com-
ponent highlights differences between spectra of pure DOPC with re-
spect to the two protein-containing systems, with the latter exhibiting
PC3 scores spread out through PC3 score axis. However, the mean PC3
score is higher for [1-93]ApoA-I (triangles) than for full-length ApoA-I
(squares), therefore suggesting a more pronounced effect of [1-93]
ApoA-I with respect to the full-length protein on the lipid membrane
(Fig. 4A). PC3 loading is quite complex, presenting both positive and
Fig. 4. PC analysis of DOPC–GUVs upon interactionwith ApoA-Iﬁbrillogenic polypeptide or the full-length protein. (A) Score plot relative to the PC analysis of DOPC–GUV spectra acquired
at τ0. Points corresponding to [1-93]ApoA-I–GUV complexes and ApoA-I–GUV spectra are represented by triangles and squares, respectively, while spectra corresponding to GUVs in the
absence of proteins are represented by dots. (B) Cumulative variance for the ﬁrst 5 PCs.
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close proximity with a negative feature at 1460 cm -1, and this, as for
PC2, can be read in terms of a higher interchain order. Notably, PC3 load-
ing also exhibits relatively sharp bands at 1063 and 1128 cm -1, which
are all correlated to C\\C vibrations of trans isomers, indicating that
the increase in PC3 scores implies an increased number of trans isomers.
The corresponding decrease of gauche isomers is, instead, pointed out
by the negative load peak at ~1080 cm -1. Therefore, PC3 highlights
the presence of lipid structures characterized by a higher order in both
intermolecular and intramolecular acyl chains.
As for the DPPC case, we also analyzed the time evolution of single,
optically trapped GUVs. However, in this case, the time evolution was
followed by PC analysis of single GUVs spectrally interrogated while
interacting with polypeptides/proteins (no meaningful data can be ex-
tracted for DOPC-–GUVs in aqueous buffer) Fig. 6 reports the PC1
score evolution for the two protein-containing samples. Interestingly,
both sets of data suggest a faster interaction with respect to DPPC–
GUVs,with a steady state reached upon 10min incubation. This outcome
could be due to the higher ﬂuidity of DOPC bilayer.Fig. 5. Analysis of the interaction of ApoA-I and [1-93]ApoA-I with DOPC–GUVs by PCA.
PC1-, PC2- and PC3-loading plot (curves A, B and C, respectively) resulting from the
analysis of all the 120 GUV spectra.4. Conclusions
Globally, our results indicate that the interaction features of [1-
93]ApoA-I with eukaryotic membranes strongly depend on the lipid
phase. In particular, ApoA-I N-terminal ﬁbrillogenic polypeptide was
found to induce a conformational disorder in ordered gel lipid bilayers.
In addition, the ﬁbrillogenic polypeptide was also found to induce
changes in vibrations close to the polar part of phospholipids, in partic-
ular in PO 2- stretching band. On the basis of this observation, we conjec-
ture that a signiﬁcant portion of [1-93]ApoA-I molecules is not deeply
buried inside the bilayer, but remains in close proximity to the mem-
brane–water interface. Similar effects, even if signiﬁcantly less pro-
nounced, were observed when DPPC–GUVs were incubated with full-
length ApoA-I.
We also provide evidence that [1-93]ApoA-I is able to interact with
liquid-like lipid bilayers, simulated by DOPC–GUVs. In this case, we an-
alyzed our data set by PCAanddemonstrated that [193]ApoA-I polypep-
tide can reside within the lipid bilayer, inducing an additional pressure
between adjacent lipid chains. This limits chain movements and favors
the more ordered CH bending mode in CH 2 with respect to that in
CH 3. We also observed a reduction of C_C band, probably ascribed toFig. 6. Kinetic analysis of protein–DOPC–GUV interaction. PC1-score time evolution for a
single optically trapped GUV interacting with [1-93]ApoA-I (A) and ApoA-I (B) molecules.
801G. Rusciano et al. / Biochimica et Biophysica Acta 1860 (2016) 795–801reducedmobility of C_C bonds due to the peptide residence in the kink
region of lipid chains. Interestingly, our analyses on DOPC-–GUVs sug-
gest the absence of a signiﬁcant interaction of either [1-93]ApoA-I or
ApoA-I with lipid polar heads. This could indicate that, in the ﬂuid
(L α) phase, protein species tend to penetrate themembrane bilayer, in-
stead of remaining in proximity to the lipid–water interface. This obser-
vation is also in agreement with the reported existence of plasma
membrane areas endowed with high afﬁnity for full-length ApoA-I
[41], as well as with our previous results indicating that [1-93]ApoA-I
polypeptide is efﬁciently internalized and subsequently degraded in
target cells [42]. To our knowledge, the ability of the polypeptide to pen-
etrate membrane ﬂuid phases inducing an alignment of lipid chains has
not been previously described. This indicates that the polypeptide may
alter the bilayer mechanical stability, with effects similar to those in-
duced by cholesterol [43–45], an event that might play an important
role in the development of the pathology.
Globally, our observations, revealing the speciﬁc ability of a natively
unfolded pathogenic polypeptide to insert in, and possibly to cross cell
membranes, provide a contribute to shed light on the intriguing and
still largely unknown molecular level details of its interaction with bio-
logical membranes.
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